Rosecure Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.30 Cr
- Revenue Growth 36.77%
- Profit Growth -3.09%
- Ebitda 47.20%
- Net Worth 3.24%
- Total Assets 36.60%
About Rosecure Pharma
Rosecure Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 June 2017 (Seven years and seven months 5 days old ). Its registered office is in New Patel Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.30 Cr.
Abhishek Pahariya, Lokesh Pahariya, and Deepesh Pahariya serve as directors at the Company.
Company Details
-
Location
New Patel Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2017PTC094530
-
Company No.
094530
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jun 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Rosecure Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Pahariya
|
Director | 30-Nov-2020 | Current |
|
Lokesh Pahariya
|
Director | 30-Nov-2020 | Current |
|
Deepesh Pahariya
|
Director | 30-Nov-2020 | Current |
Financial Performance of Rosecure Pharma.
Rosecure Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.77% increase. The company also saw a slight decrease in profitability, with a 3.09% decrease in profit. The company's net worth moved up by a moderate rise of 3.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rosecure Pharma?
In 2023, Rosecure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.30 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 3.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2023 | Others | ₹2.00 Cr | Open |
| 01 Nov 2021 | Others | ₹2.47 M | Open |
| 16 Jun 2020 | Others | ₹0.50 M | Open |
| 20 Sep 2019 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Rosecure Pharma?
Rosecure Pharma has a workforce of 6 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rosecure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosecure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
